Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010

• Main Authors: Li Changqing, Xiao Xiaopu, Yin Huimin, He Miao, Li Jianping, Dai Yudong, Fu Yongshui, Ge Jianmin, Yang Yonglin, Luan Yan, Lin Changzhou, Zhao Hongxiang, Li Wuping
• Format: Article
• Language: English
• Published: BMC 2012-08-01
• Series: Journal of Translational Medicine
• Subjects: Transfusion; Prevalence; HIV; HBV; HCV; Syphilis
• Online Access: http://www.translational-medicine.com/content/10/1/176

<p>Abstract</p> <p>Background</p> <p>In China, high prevalence of HBV and HCV parallels with the growing epidemic of syphilis and HIV in the general population poses a great threat to blood safety. This study investigated the prevalence of serologic markers for transfusion transmissible infections (TTIs) among four Chinese blood centers.</p> <p>Methods</p> <p>We examined whole blood donations collected from January 2000 through December 2010 at four Chinese blood centers. Post-donation testing of TTIs (HIV, HBV, HCV and syphilis) were conducted using two different enzyme-linked immunosorbent assay kits for each seromarker. The prevalence of serologic markers for TTIs (%) was calculated and additional analysis was conducted to examine donor characteristics associated with positive TTIs serology.</p> <p>Results</p> <p>Of the 4,366,283 donations, 60% were from first-time donors and 40% were from repeated donors. The overall prevalence of HIV, HBsAg, HCV and syphilis was 0.08%, 0.86%, 0.51% and 0.47%, respectively. The prevalence profile of TTIs varied among different blood centers and appeared at relatively high levels. Overall, the prevalence of HBsAg and HCV demonstrated a decline trend among four blood centers, while the prevalence of HIV and syphilis displayed three different trends: constantly steady, continually increasing and declining among different centers.</p> <p>Conclusions</p> <p>This study reflects the risk of TTIs has been greatly reduced in China, but blood transfusion remains an ongoing risk factor for the spread of blood-borne infections, and further work and improvements are needed to strengthen both safety and availability of blood in China.</p>